A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Category: Medical Research
Why Frankenstein matters, now, to you
Stanford anesthesiologist and writer Audrey Shafer reflects on the importance of considering the scientific and ethical issues raised by Frankenstein.
Advanced cell-labeling technology identifies suspect cell type, possible new therapeutic approach to multiple sclerosis
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
Social media gives early clues to adverse drug reactions in cancer, Stanford researchers find
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
Celiac disease may have an “off” switch, new study suggests
Researchers have found a way to turn off a key driver of inflammation in celiac disease, an autoimmune disease that affects millions of Americans.
Coordinately altered protein/receptor combo could eliminate side effects of promising anti-cancer therapy
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
A cheaper, faster, more reliable test for TB developed by Stanford researchers
Tuberculosis is a major public health problem worldwide, yet most people lack access to quick, reliable testing. Now, chemists have found a solution.
Pushing boundaries, Stanford researcher explores growing human organs in animals
Stanford researcher Hiromitsu Nakauchi explores his dream of growing custom-made, transplantable human organs in large animals, despite funding difficulties.
From hand-washing to cancer detection: Why the pace of medicine is just right
Should research findings be moved to the clinic as soon as possible or should things move more slowly for patient safety? A med student explores the issues.
Defects in mitochondria, cells’ internal power packs, further linked to Parkinson’s in Stanford study
New research suggests that targeting mitochondria could be a way to treat Parkinson's disease.
In study, Stanford researchers analyze ovarian cancer cells at unprecedented level of specificity
This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
“Slow and steady wins this race”: Stanford pain specialist studies opioid tapering
Stanford pain expert Beth Darnall discusses her clinical trials on methods to taper opioid doses for patients with chronic pain.
Stanford researchers show how mental rehearsal prepares our minds for action
Mentally running through a routine improves performance. A new tool – brain-machine interface – sheds light on how.
Debating low-fat vs low-carb diets? New study found a draw
A comparison of diets for weight loss for those with different levels of insulin and metabolic genes did not find a clear winner.
Expanding hepatitis C testing to all adults is cost-effective and improves health, new study shows
Even adults who are not considered "high-risk" should be tested to reduce deaths and improve cure rates, new Stanford Health Policy research suggests.
Exercise elevates blood signature difference between people with, without chronic fatigue syndrome
A new study suggests that a blood test following exercise may be a good way to differentiate between people who have ME/CFS and people who don't.